{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:52:12Z","timestamp":1790315532969,"version":"4.1.0"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec010\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Androgenetic alopecia (AGA) is extremely prevalent with a multifactorial etiology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec011\">\n                    <jats:title>Materials<\/jats:title>\n                    <jats:p>We conducted a cross-sectional study using the All of US (AoU) dataset Sept 2024 to better understand the epidemiology, social determinants and management of AGA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec012\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Most males were 20\u201339 years old and females 60\u201369 years old. Men typically have an earlier onset of AGA than females. Male AGA is generally managed with finasteride; oral minoxidil is prescribed in younger males. Females are prescribed spironolactone and oral minoxidil with finasteride in post-menopausal females. There was very little dutasteride prescribed. Topical minoxidil is available over the counter and was not evaluated. Early in 2011 there were reports of the Post-Finasteride Syndrome (PFS); subsequently, the finasteride prescription rate fell to about 10\u201320% of the pre-PFS prescription rate. There was increased reporting for AGA in those who drink, have an annual household income \u2265$75,000, and those with a higher level of education. There was also higher reporting of female AGA in those with anxiety and depression. Patients with higher income and education may have less pressing medical concerns enabling them to bring their AGA to the physician\u2019s attention. Females in whom the AGA affects their anxiety and depression may seek help for the AGA as a way to address their underlying disorder.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec013\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study provides a snapshot of the epidemiology and management of AGA in the USA. AGA is linked to the social determinants of health; addressing the AGA may help better manage the underlying mental and physical state.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0319040","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T13:25:30Z","timestamp":1740662730000},"page":"e0319040","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Epidemiological landscape of androgenetic alopecia in the US: An All of Us cross-sectional study"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8664-7723","authenticated-orcid":true,"given":"Aditya K.","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Economopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"issue":"8","key":"pone.0319040.ref001","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s40265-023-01880-x","article-title":"Androgenetic alopecia: therapy update","volume":"83","author":"S Devjani","year":"2023","journal-title":"Drugs"},{"issue":"1","key":"pone.0319040.ref002","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12020-017-1280-y","article-title":"Androgenetic alopecia: a review","volume":"57","author":"F Lolli","year":"2017","journal-title":"Endocrine"},{"issue":"3","key":"pone.0319040.ref003","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4103\/ijdvl.IJDVL_262_17","article-title":"Genetic and molecular aspects of androgenetic alopecia","volume":"84","author":"L Martinez-Jacobo","year":"2018","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"10","key":"pone.0319040.ref004","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.4065\/80.10.1316","article-title":"Psychological effect, pathophysiology, and management of androgenetic alopecia in men","volume":"80","author":"D Stough","year":"2005","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"pone.0319040.ref005","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/jocd.15605","article-title":"Alopecia areata and pattern hair loss (androgenetic alopecia) on social media - current public interest trends and cross-sectional analysis of YouTube and TikTok contents","volume":"22","author":"AK Gupta","year":"2023","journal-title":"J Cosmet Dermatol"},{"issue":"4","key":"pone.0319040.ref006","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.abd.2022.09.006","article-title":"Female-pattern hair loss: therapeutic update","volume":"98","author":"P M\u00fcller Ramos","year":"2023","journal-title":"An Bras Dermatol"},{"issue":"2","key":"pone.0319040.ref007","doi-asserted-by":"crossref","first-page":"54","DOI":"10.17925\/EE.2023.19.2.10","article-title":"An update on alopecia and its association with thyroid autoimmune diseases","volume":"19","author":"D Aboalola","year":"2023","journal-title":"touchREV Endocrinol"},{"issue":"3","key":"pone.0319040.ref008","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3390\/biomedicines12030513","article-title":"The hormonal background of hair loss in non-scarring alopecias","volume":"12","author":"B Owecka","year":"2024","journal-title":"Biomedicines"},{"issue":"6","key":"pone.0319040.ref009","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.jaad.2018.06.072","article-title":"How to navigate dermatology care for the uninsured","volume":"80","author":"S Shwe","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"pone.0319040.ref010","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jaad.2021.12.061","article-title":"Racial\/ethnic health disparities in dermatology in the United States, part 1: Overview of contributing factors and management strategies","volume":"87","author":"J Hooper","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"pone.0319040.ref011","first-page":"27","article-title":"Disparities in dermatology: a reflection","volume":"15","author":"N El-Kashlan","year":"2022","journal-title":"J Clin Aesthet Dermatol"},{"issue":"8","key":"pone.0319040.ref012","doi-asserted-by":"crossref","first-page":"100570","DOI":"10.1016\/j.patter.2022.100570","article-title":"The All of Us research program: data quality, utility, and diversity","volume":"3","author":"AH Ramirez","year":"2022","journal-title":"Patterns (N Y)"},{"key":"pone.0319040.ref013","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev-biodatasci-122120-104825","article-title":"The All of Us data and research center: creating a secure, scalable, and sustainable ecosystem for biomedical research","volume":"6","author":"KR Mayo","year":"2023","journal-title":"Annu Rev Biomed Data Sci"},{"issue":"7","key":"pone.0319040.ref014","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMsr1809937","article-title":"The \u201cAll of Us\u201d research program","volume":"381","author":"All of Us Research Program Investigators","year":"2019","journal-title":"N Engl J Med"},{"issue":"5","key":"pone.0319040.ref015","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4103\/0378-6323.116730","article-title":"Androgenetic alopecia: an update","volume":"79","author":"F Kaliyadan","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"12","key":"pone.0319040.ref016","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1111\/jocd.14537","article-title":"Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics","volume":"20","author":"MS Nestor","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"pone.0319040.ref017","unstructured":"Teva Canada Limited. Product monograph - TEVA-Sprionolactone (Tablets, 25\u2009mg and 100\u2009mg, Oral). 2024. Available from: https:\/\/pdf.hres.ca\/dpd_pm\/00066787.PDF"},{"issue":"4","key":"pone.0319040.ref018","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s41443-022-00612-1","article-title":"Global online interest in finasteride sexual side effects","volume":"36","author":"K Asanad","year":"2024","journal-title":"Int J Impot Res"},{"key":"pone.0319040.ref019","author":"JAMP Pharma Corporation","year":"2019","journal-title":"Product monograph - JAMP Dutasteride"},{"key":"pone.0319040.ref020","year":"2013","journal-title":"Product monograph - Loniten (Minoxidil tablets USP) 2.5\u2009mg and 10 mg"},{"issue":"6","key":"pone.0319040.ref021","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.jaad.2024.07.1523","article-title":"Examining blood pressure changes with spironolactone for alopecia: a retrospective analysis","volume":"91","author":"D Desai","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"pone.0319040.ref022","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/j.1365-2133.2003.05565.x","article-title":"Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors","volume":"149","author":"G Severi","year":"2003","journal-title":"Br J Dermatol"},{"key":"pone.0319040.ref023","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2147\/CCID.S231940","article-title":"Androgenetic alopecia: relationship to anthropometric indices, blood pressure and life-style habits","volume":"13","author":"M Danesh-Shakiba","year":"2020","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"8","key":"pone.0319040.ref024","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/ijd.13652","article-title":"The combination of overweight and smoking increases the severity of androgenetic alopecia","volume":"56","author":"C Fortes","year":"2017","journal-title":"Int J Dermatol"},{"issue":"3","key":"pone.0319040.ref025","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0022-202X.2004.23237.x","article-title":"Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia","volume":"123","author":"IM Hadshiew","year":"2004","journal-title":"J Invest Dermatol"},{"issue":"2","key":"pone.0319040.ref026","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jaad.2021.11.013","article-title":"The inflammatory component of androgenetic alopecia","volume":"86","author":"WR Heymann","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"pone.0319040.ref027","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrn1700","article-title":"Role of the immune system in chronic pain","volume":"6","author":"F Marchand","year":"2005","journal-title":"Nat Rev Neurosci"},{"issue":"12","key":"pone.0319040.ref028","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1093\/jamia\/ocae236","article-title":"Navigating electronic health record accuracy by examination of sex incongruent conditions","volume":"31","author":"L Cai","year":"2024","journal-title":"J Am Med Inform Assoc"},{"issue":"6","key":"pone.0319040.ref029","doi-asserted-by":"crossref","first-page":"e205867","DOI":"10.1001\/jamanetworkopen.2020.5867","article-title":"Frequency and types of patient-reported errors in electronic health record ambulatory care notes","volume":"3","author":"SK Bell","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"10","key":"pone.0319040.ref030","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/ejp.1459","article-title":"Self-medication in pain management: the state of the art of pharmacists\u2019 role for optimal over-the-counter analgesic use","volume":"23","author":"S Perrot","year":"2019","journal-title":"Eur J Pain"},{"issue":"13","key":"pone.0319040.ref031","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s40265-014-0245-1","article-title":"Socioeconomic impact of seasonal (epidemic) influenza and the role of over-the-counter medicines","volume":"74","author":"ME Klepser","year":"2014","journal-title":"Drugs"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0319040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T13:25:47Z","timestamp":1740662747000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0319040"}},"subtitle":[],"editor":[{"given":"Fabio Vasconcellos","family":"Comim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0319040","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]}}}